This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Sara Mangsbo, PhD
Senior Associate Lecturer at Uppsala University

Profile

Sara Mangsbo (PhD) is Associate senior lecturer in antibody drugs and Associate professor in Experimental clinical immunology at Uppsala University. Dr Mangsbo is a leader in the field of cancer immunotherapy and specifically in antibody-based drug delivery and synthetic long peptides and was recently awarded the SITC team award within the SLP stream. She is a serial entrepreneur and has founded Immuneed AB, a service provider of immunotoxicity measurements in human whole blood. She is the Chief Development Officer of Ultimovacs and the co-founder of STRIKE pharma AB. She drives a translational research project with the ambition and track-record of taking research projects into clinical trial testing.

Agenda Sessions

  • An Adaptable Antibody-based Platform for Flexible Synthetic Peptide-based Cargo Delivery Based on Agonistic CD40-directed Antibodies

    15:30
  • Payloaded Antibodies and Immune-oncology – Crossroads

    15:45